Raymond James Financial
AMPH icon

Raymond James Financial’s Amphastar Pharmaceuticals AMPH Stock Holding History

Raymond James Financial’s Portfolio AMPH Stock Details AMPH Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q3 		$445K Sell
17,239
-2,074
-11% -$44.8K ﹤0.01% 4642
2026
Q2 		$390K Buy
19,313
+258
+1% +$5.2K ﹤0.01% 4675
2026
Q1 		$373K Sell
19,055
-65,399
-77% -$1.6M ﹤0.01% 4540
2025
Q4 		$2.26M Sell
84,454
-33,733
-29% -$869K ﹤0.01% 3176
2025
Q3 		$3.15M Buy
118,187
+1,068
+0.9% +$27.6K ﹤0.01% 2815
2025
Q2 		$2.69M Buy
117,119
+87,447
+295% +$2.17M ﹤0.01% 2837
2025
Q1 		$860K Sell
29,672
-63,232
-68% -$2.02M ﹤0.01% 3597
2024
Q4 		$3.45M Buy
+92,904
New +$4.25M ﹤0.01% 2577

Other funds holding AMPH

BlackRock
BlackRock New York $6.79T AUM 37.06% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $551B AUM 33.95% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.44T AUM 36.12% 1-Year Est. Return
American Century Companies
American Century Companies Kansas City, Missouri $229B AUM 33.35% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.76T AUM
Marshall Wace
Marshall Wace London, United Kingdom $114B AUM 35.47% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.92T AUM 36.1% 1-Year Est. Return
Fuller & Thaler Asset Management
Fuller & Thaler Asset Management San Mateo, California $33.9B AUM 47.7% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.21T AUM
LSV Asset Management
LSV Asset Management Chicago, Illinois $54.1B AUM 39.29% 1-Year Est. Return

Raymond James Financial's AMPH Position: Q3 2026 in Review

Raymond James Financial reduced its Amphastar Pharmaceuticals (AMPH) stake by 11% in Q3 2026, selling an estimated $44.8K and leaving 17,239 shares worth $445K. The position accounts for ﹤0.01% of the portfolio, ranked #4642.

Raymond James Financial first reported a position in AMPH in Q4 2024 and has held it in 8 quarters since. The position peaked at $3.45M in Q4 2024. 175 funds tracked by Wall St. Rank hold AMPH as of Q3 2026.

  • Raymond James Financial held 17,239 shares of Amphastar Pharmaceuticals worth $445K as of Q3 2026.
  • Raymond James Financial sold 2,074 Amphastar Pharmaceuticals shares in Q3 2026, an estimated $44.8K.
  • Amphastar Pharmaceuticals made up ﹤0.01% of Raymond James Financial's portfolio in Q3 2026, its #4642 holding.
  • Raymond James Financial first reported a position in Amphastar Pharmaceuticals in Q4 2024 and has held it in 8 quarters since.
  • Raymond James Financial's Amphastar Pharmaceuticals position peaked at $3.45M in Q4 2024.
  • 175 funds tracked by Wall St. Rank held Amphastar Pharmaceuticals as of Q3 2026.

Based on Raymond James Financial's 13F filing for Q3 2026, filed 12 Nov 2026.